Literature DB >> 18798112

Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab.

Maria K Angelopoulou, Gerassimos A Pangalis, Sotirios Sachanas, Styliani I Kokoris, Konstantinos Anargyrou, Zaharoula Galani, Christina Kalpadakis, Theodoros P Vassilakopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18798112     DOI： 10.1080/10428190802163289

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

Review 1.  Hairy cell leukemia: present and future directions.

Authors:  Robert J Kreitman
Journal:  Leuk Lymphoma       Date:  2019-05-09

2.  Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.

Authors:  Mauricio Burotto; Maryalice Stetler-Stevenson; Evgeny Arons; Hong Zhou; Wyndham Wilson; Robert J Kreitman
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

Review 3.  Hairy cell leukemia-new genes, new targets.

Authors:  Robert J Kreitman
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

Review 4.  Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy.

Authors:  Deborah A Thomas; Farhad Ravandi; Michael Keating; Hagop M Kantarjian
Journal:  Leuk Lymphoma       Date:  2009-10

Review 5.  Approach to the patient after relapse of hairy cell leukemia.

Authors:  Robert J Kreitman; David J P Fitzgerald; Ira Pastan
Journal:  Leuk Lymphoma       Date:  2009-10

6.  Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia.

Authors:  Robert J Kreitman; Claire Dearden; Pier Luigi Zinzani; Julio Delgado; Lionel Karlin; Tadeusz Robak; Douglas E Gladstone; Philipp le Coutre; Sascha Dietrich; Mirjana Gotic; Loree Larratt; Fritz Offner; Gary Schiller; Ronan Swords; Larry Bacon; Monica Bocchia; Krimo Bouabdallah; Dimitri A Breems; Agostino Cortelezzi; Shira Dinner; Michael Doubek; Bjorn Tore Gjertsen; Marco Gobbi; Andrzej Hellmann; Stephane Lepretre; Frederic Maloisel; Farhad Ravandi; Philippe Rousselot; Mathias Rummel; Tanya Siddiqi; Tamar Tadmor; Xavier Troussard; Cecilia Arana Yi; Giuseppe Saglio; Gail J Roboz; Kemal Balic; Nathan Standifer; Peng He; Shannon Marshall; Wyndham Wilson; Ira Pastan; Nai-Shun Yao; Francis Giles
Journal:  Leukemia       Date:  2018-07-20       Impact factor: 11.528
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.